FOUNDERS
Le Dam MD MPH
Swayambu Raparti
Le Dam MD MPH
CEO
Le is a medical doctor and experienced startup leader in developing hardware, software, and AI/ML medical device solutions that deliver value to clinicians and patients. She managed a network of clinicians and healthcare leaders committed to developing innovative technologies to improve health outcomes and decrease the burden on clini
CEO
Le is a medical doctor and experienced startup leader in developing hardware, software, and AI/ML medical device solutions that deliver value to clinicians and patients. She managed a network of clinicians and healthcare leaders committed to developing innovative technologies to improve health outcomes and decrease the burden on clinicians and the healthcare system.
Le previously secured 5.7 million in federal SBIR grant funding and supported several successful regulatory submissions including FDA 510k and Breakthrough Device Designation.
She conducted and published public health research and guidelines in collaboration with The University of Melbourne for the National Health and Medical Research Council in Australia.
Le received her BA from UCLA, Masters of Public Health from the University of Queensland, and her medical degree from the University of Notre Dame Sydney School of Medicine.
Rene Gilvert
Swayambu Raparti
Le Dam MD MPH
Chair and COO
René is a life science professional with more than 25 years of pharmaceutical commercial and development experience in GSK, Organon, Novartis and Takeda
Former Vice President of Global Franchises in Neuroscience and CVM at Takeda
René has more than 10 years of leadership experience in developing Digital Solutions , at both No
Chair and COO
René is a life science professional with more than 25 years of pharmaceutical commercial and development experience in GSK, Organon, Novartis and Takeda
Former Vice President of Global Franchises in Neuroscience and CVM at Takeda
René has more than 10 years of leadership experience in developing Digital Solutions , at both Novartis and Takeda, where he developed Digital Medicine concepts in NeuroPsychiatric disorders.
René holds a B.Sc in Information Management from the University of Applied Sciences Larenstein and has Executive Training certification in Finance from the Harvard Business School
Swayambu Raparti
Swayambu Raparti
Swayambu Raparti
CTO
Raparti has over two decades of software development experience, including over 14 years of building healthcare technology platforms to democratize data.
He has built platforms that leverage a variety of techniques, including native cloud, edge computing, IoT and AI/ML, to collect and organize information from EHRs/EMRs, LIMS/LIS, pati
CTO
Raparti has over two decades of software development experience, including over 14 years of building healthcare technology platforms to democratize data.
He has built platforms that leverage a variety of techniques, including native cloud, edge computing, IoT and AI/ML, to collect and organize information from EHRs/EMRs, LIMS/LIS, patient portals, and lab work flows.
Mr. Raparti manages the Software Development, Enterprise IT and Data Science teams to design, develop and deliver high traffic, large scale technology platforms to enable integrations, interoperability and data insights.
Raparti has held several software technical lead and senior engineering leadership roles at Sema4, Equinix, eProcrates, Cryptography, and Genentech.
Raparti has a Master of Science in Computer Software from Carnegie Mellon University.
TeaM
Roger Bullock MD
Anna Grabowski MSc
Anna Grabowski MSc
Medical Officer
Roger qualified in medicine 1981 and has worked in surgery, medicine and A&E until training in psychiatry 1987-1990.
Specialized in geriatric psychiatry.
NHS consultant 1993-2013
Set up Kingshill Research Centre in 1994 developing it in to a national and international facility.
UK coordinating investigator on many occasions
Medical Officer
Roger qualified in medicine 1981 and has worked in surgery, medicine and A&E until training in psychiatry 1987-1990.
Specialized in geriatric psychiatry.
NHS consultant 1993-2013
Set up Kingshill Research Centre in 1994 developing it in to a national and international facility.
UK coordinating investigator on many occasions. Published over 100 peer reviewed papers, several books and chapters and
8 years as clinical tutor and 4 years as Academic Secretary of the Royal College of Psychiatrists Faculty of Old age Psychiatry. Invited speaker at many national and international conferences
Worked 11 years in senior NHS management - last six as Clinical director of Older Peoples services.
Successfully responsible for a 55m budget and clinical governance of 800 staff
Anna Grabowski MSc
Anna Grabowski MSc
Anna Grabowski MSc
Financial Officer
Anna has significant experience in controlling, strategy & risk management with major global fast moving consumer good companies.
She is the Head of Basel Section and Board member of the Swiss Hospital Service of the Order of Malta.
Anna holds an M.Sc. (cum laude) International Management/CEMS from Rotterdam School of Mana
Financial Officer
Anna has significant experience in controlling, strategy & risk management with major global fast moving consumer good companies.
She is the Head of Basel Section and Board member of the Swiss Hospital Service of the Order of Malta.
Anna holds an M.Sc. (cum laude) International Management/CEMS from Rotterdam School of Management and executive education at IMD Lausanne and IESE Business School.
Anna is an alumna of Evonik’s RISE talent program and a One Young World Ambassador
Albrecht Tribukait PhD MDA
Albrecht Tribukait PhD MDA
Albrecht Tribukait PhD MDA
Regs and Compliance Officer
Albrecht is a transformational leader with an international career of more than 20 years at the interface of science, policy and regulation in fast-paced Biotech and FMCG environments of significant growth.
Extensive experience in national and supranational regulation of consumer products and non-food products.
A
Regs and Compliance Officer
Albrecht is a transformational leader with an international career of more than 20 years at the interface of science, policy and regulation in fast-paced Biotech and FMCG environments of significant growth.
Extensive experience in national and supranational regulation of consumer products and non-food products.
Albrecht has conducted, directed, commissioned and published scientific and clinical research, and forged first-in-class partnerships with NGO and strategic collaboration with government-owned research organisations advancing evidence-informed approaches to public health policy and practice.
Ph.D. in Natural Sciences from the University of Göttingen, MBA from Anaheim University Akio Morita School of Business, postgraduate certificates from Oxford and Hull.
Mark Edwards
Albrecht Tribukait PhD MDA
Albrecht Tribukait PhD MDA
Corporate Secretary
Mark has 27 years of global legal experience
Former Vice President and General Counsel of Butamax®Advanced Biofuels LLC (Joint Venture between BP and DuPont)
He was General Counsel and Compliance Officer of Ilera Healthcare, a successful startup
Corporate Intellectual Property Litigation Counsel for DuPont strategic b
Corporate Secretary
Mark has 27 years of global legal experience
Former Vice President and General Counsel of Butamax®Advanced Biofuels LLC (Joint Venture between BP and DuPont)
He was General Counsel and Compliance Officer of Ilera Healthcare, a successful startup
Corporate Intellectual Property Litigation Counsel for DuPont strategic businesses - 13 years
Extensive technology, licensing and commercial transaction experience
Registered U.S. Patent Attorney - United States Patent and Trademark OfficeIntellectual Property consultant for startups and emerging companies
B.A. Chemistry - Kenyon College
the company behind myAVOS
OptiChroniX is a Swiss-American digital health company that aims to improve brain health for millions.
We developed myAVOS, a healthcare application that provides a late-life dementia risk calculator, continuous screening for cognitive change, focusing on modifiable factors in one's lifestyle and health status as early as for people in their mid fifties.
myAVOS uses digital technology to personalize, track and improve brain health by collecting data from wearables and nearables, and providing tailored coaching to improve health literacy, medication adherence and positively impact modifiable factors related to cognitive decline. Forty per cent of dementia cases could be prevented or delayed by targeting modifiable risk factors.